Phase 1 biotech developing fibroblast-based therapies for chronic diseases.
Industry: Health Care
Latest Trade: $3.25 0.00 (0.0%)
First Day Return: +263.8%
Return from IPO: -59.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/07/2023 |
Offer Price | $8.00 |
Price Range $8.00 - $8.00 | |
Offer Shares (mm) | 4.8 |
Deal Size ($mm) | $0 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/31/2024 |
Offer Price | $8.00 |
Price Range $8.00 - $8.00 | |
Offer Shares (mm) | 4.8 |
Deal Size ($mm) | $0 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Maxim Group LLC |
Company Data | |
---|---|
Headquarters | Houston, TX, United States |
Founded | 2006 |
Employees at IPO | 8 |
Website www.fibrobiologics.com |